<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/E267D436-2514-489F-AC0B-D9A82EFB64B8"><gtr:id>E267D436-2514-489F-AC0B-D9A82EFB64B8</gtr:id><gtr:name>Dando, Weiss &amp; Colucci Limited</gtr:name><gtr:address><gtr:line1>MINERVA HOUSE , LOWER BRISTOL ROAD</gtr:line1><gtr:city>BATH</gtr:city><gtr:postCode>BA2 9ER</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E267D436-2514-489F-AC0B-D9A82EFB64B8" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>E267D436-2514-489F-AC0B-D9A82EFB64B8</gtr:id><gtr:name>Dando, Weiss &amp; Colucci Limited</gtr:name><gtr:address><gtr:line1>MINERVA HOUSE , LOWER BRISTOL ROAD</gtr:line1><gtr:city>BATH</gtr:city><gtr:postCode>BA2 9ER</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>23250.0</gtr:offerGrant><gtr:projectCost>31000.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F97D269A-3B18-43A3-B373-25EBF60E3F5F" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>F97D269A-3B18-43A3-B373-25EBF60E3F5F</gtr:id><gtr:name>Echino Limited</gtr:name><gtr:address><gtr:line1>73 SQUIRES LEAZE , THORNBURY</gtr:line1><gtr:city>BRISTOL</gtr:city><gtr:postCode>BS35 1TH</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>1500.0</gtr:offerGrant><gtr:projectCost>2000.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/520E66DB-9DDA-4066-B6D0-E68F386CD79B"><gtr:id>520E66DB-9DDA-4066-B6D0-E68F386CD79B</gtr:id><gtr:firstName>Jonathan</gtr:firstName><gtr:surname>Dando</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=130830"><gtr:id>5C074EBC-4830-4D07-ADA4-2E80881E1821</gtr:id><gtr:title>In vitro evaluation of the effects of Pluronic and Tetronic-Fibrinogen on survival and differentiation of mouse and human induced pluripotent stem cells-derived mesangioblasts</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Feasibility Studies</gtr:grantCategory><gtr:grantReference>130830</gtr:grantReference><gtr:abstractText>Skeletal muscle repair in pathologies such as muscular dystrophy remain a major challenge. Throughout the world, musculoskeletal impairments and conditions are the most frequent causes of disability: over 300,000 European citizens suffer from a muscular disorder. Encompassing more than 150 diseases and syndromes, musculoskeletal conditions affect every age group. Progress has been made by direct injection of cells into the diseased muscle, but fundamental hurdles in both signalling to these cells and supporting their metabolic needs remain. The solution to these problems is given by new groundbreaking biomaterials that can support the oxygenation, correct differentiation and vascularisation of the implanted cells. In this project, we describe the very first steps of proving efficacy and safety of a new biomaterial for its use for the creation of an entire artificial muscle only using a few of a patient original muscle.</gtr:abstractText><gtr:fund><gtr:end>2012-11-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2012-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>24750</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">130830</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>